Form 4 for BDSX BIODESIX INC
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-10 · accession 0000905148-25-003933 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-13 | 2025-11-10 | BDSX | Vazquez Chris | CAO | S - Sale+OE | $7.62 | -13 | 936 | -1% | -$99.06 |
| D | 2025-11-13 | 2025-11-10 | BDSX | Vazquez Chris | CAO | M - OptEx | — | +31 | 949 | +3% | — |
| D | 2025-11-13 | 2025-11-10 | BDSX | Vazquez Chris | CAO | M - OptEx | $0.00 | -31 | 29 | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-10 | S | D | 13 | $7.62 | 936 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-10 | M | A | 31 | — | 949 | D | — | — | (F1) These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025. (F2) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| 3 | Derivative | Restricted Stock Units | 2025-11-10 | M | D | 31 | $0.00 | 29 | D | — · — to — | 31 Common Stock | (F1) These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025. (F2) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F4) These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. |